Cocaine and cocaine addiction: State-of-the-art learning and current strategies

被引:1
作者
Lacoste, Jerome [1 ]
Michel, Gwladys [1 ]
Rollier, Sloane [1 ]
Charles-Nicolas, Aime [1 ]
机构
[1] CHU Martinique, Serv Psychiat & Addictol, F-97200 Fort De France, Martinique, France
来源
ANNALES MEDICO-PSYCHOLOGIQUES | 2018年 / 176卷 / 08期
关键词
Cocaine; Crack; Pharmacotherapy; Psychotherapy; RANDOMIZED-CONTROLLED-TRIAL; METHADONE-MAINTENANCE TREATMENT; FOCUSED COGNITIVE THERAPY; PLACEBO-CONTROLLED TRIAL; ALCOHOL DEPENDENCE; COOCCURRING COCAINE; DOUBLE-BLIND; NALTREXONE; BUPRENORPHINE/NALOXONE; TOPIRAMATE;
D O I
10.1016/j.amp.2018.08.015
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Until the late 1970s, cocaine use was not considered a public health problem. With the arrival of free base cocaine in the mid-1970s and crack cocaine in the early 1980s, the number of cocaine users has been steadily increasing in America and Europe, resulting in a significant increase in the number of cocaine users, but also a worrying increase in the number and severity of cocaine-related intoxications. However, there is still no pharmacological treatment that has proved its effectiveness. Psychotherapeutic approach remains the mainstay of care, which must be multidisciplinary and multimodal. Our purpose is to present a focus on state-of-the-art learning from literature review on psychotherapy and pharmacotherapy of cocaine addiction. We first describe a short history of cocaine and crack use and describe epidemiological and clinical issues relative to cocaine addiction. We then discuss current pharmacological treatments (agonist and antagonist therapies; anti-craving agents; clinical trials in humans and animal models), including strategies for cocaine use during maintenance therapy for opiate use disorders. Finally, we present neurostimulation techniques as a novel therapeutic tool to inhibit drug cue-associated behaviors and reduce cocaine craving. (C) 2018 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:778 / 782
页数:5
相关论文
共 29 条
[1]   A double blind, placebo controlled trial of modafinil for the treatment of cocaine dependence without co-morbid alcohol dependence [J].
Kampman, Kyle M. ;
Lynch, Kevin G. ;
Pettinati, Helen M. ;
Spratt, Kelly ;
Wierzbicki, Michael R. ;
Dackis, Charles ;
O'Brien, Charles P. .
DRUG AND ALCOHOL DEPENDENCE, 2015, 155 :105-110
[2]   Cocaine addiction: Current data for the clinician [J].
Karila, Laurent ;
Zarmdini, Rim ;
Petit, Aymeric ;
Lafaye, Genevieve ;
Lowenstein, William ;
Reynaud, Michel .
PRESSE MEDICALE, 2014, 43 (01) :9-17
[3]  
Lacoste J, 2010, COURRIER ADDICT, V12, P27
[4]   Addiction to cocaine and other stimulants [J].
Lacoste, Jerome ;
Delavenne-Garcia, Heloise ;
Charles-Nicolas, Aime ;
Garcia, Frederico Duarte ;
Jehel, Louis .
PRESSE MEDICALE, 2012, 41 (12) :1209-1220
[5]   Cocaine and alcohol: a risky association [J].
Lacoste, Jerome ;
Pedrera-Melgire, Manuela ;
Charles-Nicolas, Aime ;
Ballon, Nicolas .
PRESSE MEDICALE, 2010, 39 (03) :291-302
[6]   Buprenorphine plus naloxone plus naltrexone for the treatment of cocaine dependence: the Cocaine Use Reduction with Buprenorphine (CURB) study [J].
Ling, Walter ;
Hillhouse, Maureen P. ;
Saxon, Andrew J. ;
Mooney, Larissa J. ;
Thomas, Christie M. ;
Ang, Alfonso ;
Matthews, Abigail G. ;
Hasson, Albert ;
Annon, Jeffrey ;
Sparenborg, Steve ;
Liu, David S. ;
McCormack, Jennifer ;
Church, Sarah ;
Swafford, William ;
Drexler, Karen ;
Schuman, Carolyn ;
Ross, Stephen ;
Wiest, Katharina ;
Korthuis, P. Todd ;
Lawson, William ;
Brigham, Gregory S. ;
Knox, Patricia C. ;
Dawes, Michael ;
Rotrosen, John .
ADDICTION, 2016, 111 (08) :1416-1427
[7]   Memory-Focused Cognitive Therapy for Cocaine Use Disorder: Theory, Procedures and Preliminary Evidence From an External Pilot Randomised Controlled Trial [J].
Marsden, John ;
Goetz, Camille ;
Meynen, Tim ;
Mitcheson, Luke ;
Stillwell, Garry ;
Eastwood, Brian ;
Strang, John ;
Grey, Nick .
EBIOMEDICINE, 2018, 29 :177-189
[8]  
Marsden J, 2017, CONT CLIN TRIAL COMM, V8, P264, DOI 10.1016/j.conctc.2017.10.009
[9]   Aripiprazole for cocaine abstinence: a randomized-controlled trial with ecological momentary assessment [J].
Moran, Landhing M. ;
Phillips, Karran A. ;
Kowalczyk, William J. ;
Ghitza, Udi E. ;
Agage, Daniel A. ;
Epstein, David H. ;
Preston, Kenzie L. .
BEHAVIOURAL PHARMACOLOGY, 2017, 28 (01) :63-73
[10]  
Niemann A., 1860, ARCH PHARM, V153, P129, DOI [DOI 10.1002/ARDP.18601530202, 10.1002/ardp.18601530202]